Cost-Effectiveness of Semaglutide for Secondary Prevention of Cardiovascular Disease in US Adults.
Hennessy, Susan, Joanne Penko, Brandon K Bellows, Pamela G Coxson, Ross Boylan, Kendra D Sims, Alexis Beatty, et al. 2026. “Cost-Effectiveness of Semaglutide for Secondary Prevention of Cardiovascular Disease in US Adults.”. JAMA Cardiology 11 (3): 229-38.